Is a complete MRKR research report available?

No complete published report is available for Marker Therapeutics, Inc. (MRKR) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Marker Therapeutics, Inc. (MRKR)

NASDAQ: MRKR · USD

$1.27

+0.03 (+2.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-24 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first MRKR analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	21.2M
Revenue (ttm)	3.5M
Net income (ttm)	-10.9M
EPS (ttm)	-$0.63
Shares out	16.7M
Volume	14,248.03
Beta	1.45
Price target	$7.87	+519.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.5M
Net income (ttm): -10.9M
EPS (ttm): -$0.63
Market cap: 21.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All MRKR indicators

Market & fundamental data

Available fields

208

Groups with data

Currency

USD

Showing 208 of 208 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001094038
Company name	Marker Therapeutics, Inc.
Country	United States
Country code	US
Cusip	57055L206
Employees	5
Employees Change	-3%
Employees Change Percent	-37.5
Enterprise value	$5.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US57055L2060
Last refreshed	2026-07-24
Market cap	$21.2M
Market cap category	Nano-Cap
Price	$1.27
Price currency	USD
Rev Per Employee	709,333.8x
Sector	Healthcare
Sector PE	44.59
Sector PE Fwd	23.48
Sic	2834
Symbol	MRKR
Website	https://markertherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-53.5%
EV Sales Forward	1.73x
EV/Sales	1.54x
FCF yield	-38.88%
P/B ratio	1.5x
P/S ratio	5.74x
PS Forward	6.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-386.37%
EBITDA Margin	-386.37%
Gross margin	-224.43%
Gross Profit	$-8M
Net Income	$-10.9M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-307.67%
Profit Per Employee	$-2.2M
ROA	-43.59
Roa5y	-35.24
ROCE	-89.55
ROE	-77.04
Roe5y	-79.54
ROIC	-53.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-30.91%
Cagr15y	-40.72%
Cagr1y	-19.63%
Cagr20y	-39.98%
Cagr3y	-42.29%
Cagr5y	-43.83%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	-33.67x
Revenue Growth Years	0x
Revenue Growth3 Y	-2.13x
Revenue Growth5 Y	50.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.21
Assets	$17.4M
Cash	$14.9M
Current Assets	$17.4M
Current Liabilities	$3.6M
Debt	$0
Equity	$13.8M
Liabilities	$3.6M
Long Term Assets	$0
Long Term Liabilities	$0
Net Cash	$14.9M
Net Cash By Market Cap	$73.23
Net Cash Growth	8.93%
Net Debt Equity	$-1.08
Tangible Book Value	$13.8M
Tangible Book Value Per Share	$0.83
WACC	12.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.79
Net Working Capital	$-1.1M
Quick ratio	4.48
Working Capital	$13.8M
Working Capital Turnover	$0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-82.16%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-97.52%
1Y total return	-19.62%
200-day SMA	1.4
3Y total return	-80.79%
50-day SMA	1.42
50-day SMA vs 200-day SMA	50over200
5Y total return	-94.41%
All Time High	6,120,061.2
All Time High Change	-100%
All Time High Date	2002-11-14
All Time Low	0.67
All Time Low Change	89.38%
All Time Low Date	2023-03-31
ATR	0.07
Beta	1.45
Beta1y	2.13
Beta2y	1.85
Ch YTD	-14.77
High	1.31
High52	2.46
High52 Date	2026-01-08
High52ch	-48.37%
Low	1.22
Low52	0.81
Low52 Date	2025-08-28
Low52ch	56.81%
Ma50ch	-10.37%
Price vs 200-day SMA	-9.16%
RSI	37.95
RSI Monthly	40.63
RSI Weekly	45.1
Sharpe ratio	0.09x
Sortino ratio	0.21
Total Return	-82.16%
Tr YTD	-14.77
Tr15y	-99.96%
Tr1m	-7.3%
Tr1w	-5.22%
Tr3m	-17.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$10
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.18
Earnings Revenue Estimate	665,600x
Earnings Revenue Estimate Growth	-22.71x
Operating Income	$-12M
Operating margin	-338.5
Price target	$7.87
Price Target Change	$520
Price Target Change Top	$687

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,743,967%
Float Percent	82.43%
Shares Insiders	7.82%
Shares Institutions	17.55%
Shares Out	16,673,127
Shares Qo Q	-0.23%
Shares Yo Y	82.16%
Short Float	0.85%
Short Ratio	1.99
Short Shares	0.7

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.3M
Average Volume	65,973.8x
Bv Per Share	0.83
Ch10y	-97.52
Ch15y	-99.96
Ch1m	-7.3
Ch1w	-5.22
Ch1y	-19.62
Ch20y	-100
Ch3m	-17.53
Ch3y	-80.79
Ch5y	-94.41
Ch6m	-37.75
Change	2.42%
Change From Open	3.25
Close	1.24
Days Gap	-0.81
Dollar Volume	18,095
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-12.4M
EBITDA	$-12.4M
EPS	$-0.63
F Score	1
FCF	$-7.9M
FCF EV Yield	-145.23x
FCF Per Share	$-0.47
Financing CF	9,863,983
Fiscal Year End	December
Founded	1,999
Income Tax	$-15,156
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2023-01-27
Last Split Type	Reverse
Last10k Filing Date	2026-03-18
Ma150	1.5
Ma150ch	-15.39%
Ma20	1.42
Ma20ch	-10.44%
Net CF	1,945,447
Next Earnings Date	2026-08-13
Open	1.23
Optionable	No
Position In Range	55.81
Post Close	1.27
Postmarket Change Percent	0.79
Postmarket Price	$1.28
Price Date	2026-07-23
Ptbv Ratio	1.48
Relative Volume	0.22x
Revenue	3,546,669x
SBC By Revenue	9.5x
Share Based Comp	336,818
Tax By Revenue	-0.43x
Tr20y	-100%
Tr6m	-37.75%
Us State	Texas
Volume	14,248
Z Score	-35.26

Marker Therapeutics, Inc. (MRKR)

Coverage state: Market snapshot only — no published research

Generate the first MRKR analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · MRKR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MRKR indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on MRKR

Frequently asked questions